SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001387131-19-007014
Filing Date
2019-09-18
Accepted
2019-09-18 16:38:57
Documents
1
Period of Report
2019-09-12

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT stsa-form3_091219.html 3  
1 OWNERSHIP DOCUMENT stsa-form3_091219.xml 3 9254
  Complete submission text file 0001387131-19-007014.txt   11630
Mailing Address 301 COMMERCE STREET SUITE 3300 FORT WORTH TX 76102
Business Address
BONDERMAN DAVID (Reporting) CIK: 0000860866 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39041 | Film No.: 191100133

Mailing Address 301 COMMERCE STREET SUITE 3300 FORT WORTH TX 76102
Business Address
COULTER JAMES G (Reporting) CIK: 0001099776 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39041 | Film No.: 191100134

Mailing Address C/O TPG GLOBAL, LLC 301 COMMERCE STREET, SUITE 3300 FORT WORTH TX 76102
Business Address C/O TPG GLOBAL, LLC 301 COMMERCE STREET, SUITE 3300 FORT WORTH TX 76102 817-871-4000
TPG Group Holdings (SBS) Advisors, Inc. (Reporting) CIK: 0001495741 (see all company filings)

State of Incorp.: DE
Type: 3 | Act: 34 | File No.: 001-39041 | Film No.: 191100132

Mailing Address 400 OYSTER POINT BOULEVARD SUITE 221 SOUTH SAN FRANCISCO CA 64080
Business Address 400 OYSTER POINT BOULEVARD SUITE 221 SOUTH SAN FRANCISCO CA 64080 415-505-0809
Satsuma Pharmaceuticals, Inc. (Issuer) CIK: 0001692830 (see all company filings)

IRS No.: 813039831 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations